Dr. Horwitz on Updates in T-Cell Lymphoma Treatment

Video

Steven M. Horwitz, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses some new treatments on the horizon for T-cell lymphoma.

Steven M. Horwitz, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses some new treatments on the horizon for T-cell lymphoma.

Horwitz says there is a modest subgroup of patients that respond well to new agents in the relapsed setting. If researchers are able to figure out which of these patients will benefit the most in this subset it will change their prognosis significantly.

Researchers now also have a better understanding of the biology and underlying molecular mechanisms of this disease, Horwitz says. New mutations are also being discovered, which will help researchers develop new targeted agents.

Horwitz says more work needs to be done to determine which patients will benefit from novel agents in order to deliver better outcomes.

​

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
Image of a woman with white hair in front of an Oncology Nursing News blue background
2 experts are featured in this series.
Image of a man in a suit standing in front of a blue Oncology Nursing News backdrop
2 experts are featured in this series.
Image of a woman with shoulder-length black hair wearing headphones and a white sweater
Related Content